InsidersTradesSigma
Follow the Wuhan YZY Biopharma Co., Ltd. - B - H Shares stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. The latest transaction was reported on 16 June 2026 (Other). Among the most active insiders: ZHOU HONGFENG. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Wuhan YZY Biopharma Co., Ltd. is a biopharmaceutical company that provides innovative solutions for the treatment of various diseases. It is listed under the B category of H shares.